EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Humoral Immunity to Measles, Mumps, Rubella, Diphtheria, Tetanus and Pertussis After Cancer Treatment in Children

Susanna Sundell, Miia Laine, Liisa Järvelä iD, Ville Peltola, Tytti Vuorinen, Päivi Lähteenmäki, Linnea Schuez-Havupalo iD

Cancer Reports · 2025

DOI: 10.1002/cnr2.70155 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Susanna Sundell und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland. Hauptthemen laut MEDLINE: Immunity, Humoral, Neoplasms, Diphtheria-Tetanus-acellular Pertussis Vaccines. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Turku University Hospital Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Treatment for pediatric malignancies has distinct effects on the immune system.

Aims

Our aim was to measure humoral immunity to measles, mumps and rubella (MMR), and diphtheria, tetanus and acellular pertussis (DTaP) vaccines after pediatric cancer treatment.

Method

We assessed IgG titers of 52 children against the vaccine antigens post‐treatment.

Results

After completed primary vaccination series for MMR and DTaP before treatment, post‐treatment there was a considerable proportion of patients with below‐reference titers against pertussis, diphtheria and tetanus, but only few subjects showed below‐reference titers against measles, mumps and rubella. Our findings may have implications when considering re‐vaccination policies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, HumoralNeoplasmsDiphtheria-Tetanus-acellular Pertussis VaccinesHumansChildMaleFemaleChild, PreschoolMeasles-Mumps-Rubella VaccineAdolescentVaccinationAntibodies, ViralImmunoglobulin GMeaslesInfantMumps

Stichwörter der Autor:innen

childcytostatic agentshematologic neoplasmsimmune reconstitutionneoplasmsvaccination

Substanzen

Measles-Mumps-Rubella VaccineDiphtheria-Tetanus-acellular Pertussis VaccinesAntibodies, ViralImmunoglobulin G

Autor:innen und Institutionen

  • Department of Pediatrics and Adolescent Medicine, Turku University Hospital and University of Turku, Turku, Finland.
  • Department of Clinical Microbiology, Turku University Hospital and University of Turku, Turku, Finland.
  • Institute of Biomedicine, University of Turku, Turku, Finland.

ORCID-Profile: Liisa Järvelä, Linnea Schuez-Havupalo

Förderung

  • Turku University Hospital Foundation

Zitieren

APA

Sundell, S., Laine, M., Järvelä, L., Peltola, V., Vuorinen, T., Lähteenmäki, P., & Schuez-Havupalo, L. (2025). Humoral Immunity to Measles, Mumps, Rubella, Diphtheria, Tetanus and Pertussis After Cancer Treatment in Children. Cancer Reports. https://doi.org/10.1002/cnr2.70155

Vancouver

Sundell S, Laine M, Järvelä L, Peltola V, Vuorinen T, Lähteenmäki P, et al. Humoral Immunity to Measles, Mumps, Rubella, Diphtheria, Tetanus and Pertussis After Cancer Treatment in Children. Cancer Reports. 2025. doi:10.1002/cnr2.70155

BibTeX
@article{Sundell2025,
  author = {Sundell, Susanna and Laine, Miia and Järvelä, Liisa and Peltola, Ville and Vuorinen, Tytti and Lähteenmäki, Päivi and Schuez-Havupalo, Linnea},
  title = {Humoral Immunity to Measles, Mumps, Rubella, Diphtheria, Tetanus and Pertussis After Cancer Treatment in Children},
  journal = {Cancer Reports},
  year = {2025},
  doi = {10.1002/cnr2.70155}
}
Kostenlos starten →